BR112018075703A2 - microestrutura do ácido hialurônico tendo exce-lentes características de solubilidade - Google Patents

microestrutura do ácido hialurônico tendo exce-lentes características de solubilidade

Info

Publication number
BR112018075703A2
BR112018075703A2 BR112018075703-9A BR112018075703A BR112018075703A2 BR 112018075703 A2 BR112018075703 A2 BR 112018075703A2 BR 112018075703 A BR112018075703 A BR 112018075703A BR 112018075703 A2 BR112018075703 A2 BR 112018075703A2
Authority
BR
Brazil
Prior art keywords
skin
hyaluronic acid
solubility characteristics
microstructure
present
Prior art date
Application number
BR112018075703-9A
Other languages
English (en)
Inventor
Soo Kim Jae
Chang Kwon Soon
Jin Park Sang
Original Assignee
Endoderma Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endoderma Co., Ltd. filed Critical Endoderma Co., Ltd.
Publication of BR112018075703A2 publication Critical patent/BR112018075703A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Birds (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Cosmetics (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

a presente invenção refere-se a uma microestrutura de ácido hialurônico com excelentes características de solubilidade. mais especificamente, a presente invenção refere-se a uma microestrutura biodegradável que compreende o ácido hialurônico reticulado e que tem excelentes características de solubilidade durante a penetração na pele. quando a microestrutura da presente invenção é penetrada dentro da pele, as características de solubilidade na pele são excelentes, a velocidade de dissolução na pele pode ser facilmente controlada de acordo com a proporção de conteúdo do ácido hialurônico reticulado e, enquanto os ingredientes eficazes providos na microestrutura podem ser distribuídos de forma estável na pele, a velocidade de liberação dos ingredientes eficazes fornecidos pode ser facilmente controlada e, dessa forma, a presente invenção pode ser utilizada como um sistema de suprimento transdérmico para materiais farmacologicamente ativos ou materiais de melhoria da pele.
BR112018075703-9A 2016-06-16 2017-06-16 microestrutura do ácido hialurônico tendo exce-lentes características de solubilidade BR112018075703A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2016-0074985 2016-06-16
KR20160074985 2016-06-16
PCT/KR2017/006342 WO2017217818A1 (ko) 2016-06-16 2017-06-16 용해 특성이 우수한 히알루론산 마이크로구조체

Publications (1)

Publication Number Publication Date
BR112018075703A2 true BR112018075703A2 (pt) 2019-04-02

Family

ID=60663275

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018075703-9A BR112018075703A2 (pt) 2016-06-16 2017-06-16 microestrutura do ácido hialurônico tendo exce-lentes características de solubilidade

Country Status (9)

Country Link
US (1) US11013670B2 (pt)
EP (1) EP3473242A4 (pt)
JP (1) JP6900405B2 (pt)
KR (1) KR101973801B1 (pt)
CN (1) CN109310625A (pt)
BR (1) BR112018075703A2 (pt)
MX (1) MX2018015607A (pt)
TW (2) TWI718576B (pt)
WO (1) WO2017217818A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102025546B1 (ko) 2017-11-22 2019-09-26 단국대학교 천안캠퍼스 산학협력단 히알루론산-칼슘 복합체 및 알지네이트를 포함하는 약물 전달체
TR201922907A2 (tr) * 2019-12-31 2021-07-26 Vsy Biyoteknoloji Ve Ilac Sanayi Anonim Sirketi Osteoartri̇t tedavi̇si̇ i̇çi̇n yeni̇ bi̇r vi̇skoelasti̇k formülasyonu ve bunun üreti̇m yöntemi̇
EP3854375A1 (en) * 2020-01-23 2021-07-28 Paean Aesthetics Inc Micro-spicule composition to control its shape and method for producing the same
US11129788B1 (en) * 2020-03-24 2021-09-28 Elc Management Llc Sprayable film forming compositions for improving the performance of topical preparations
KR102122208B1 (ko) 2020-04-07 2020-06-12 주식회사 라파스 마이크로니들 패치를 이용한 최소 침습적 아토피 피부염 검사 방법 및 마이크로니들 패치를 포함하는 최소 침습적 아토피 검사 키트
FR3109153B1 (fr) * 2020-04-10 2022-07-15 Teoxane SA Compositions à base d’au moins deux glycosaminoglycanes
KR20230024668A (ko) * 2021-08-12 2023-02-21 주식회사 페로카 마이크로니들 패치
CN114311721B (zh) * 2021-12-27 2023-09-08 青岛农业大学 一种可食用、可生物降解餐具的制备方法
KR102643334B1 (ko) * 2022-08-23 2024-03-05 주식회사 큐에이치바이오 가교 히알루론산 및 생체 적합성 미립자를 포함하는 피부 필러 조성물, 및 그 제조방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7963997B2 (en) * 2002-07-19 2011-06-21 Kensey Nash Corporation Device for regeneration of articular cartilage and other tissue
JP3420851B2 (ja) * 1994-12-06 2003-06-30 株式会社資生堂 癒着防止剤
JP4210231B2 (ja) 2004-03-25 2009-01-14 株式会社資生堂 皮膚のシワを改善する美容方法及びシワ改善具
FR2909560B1 (fr) * 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
EP2244748B1 (en) * 2008-02-27 2018-04-11 KCI Licensing, Inc. System and method for healing a wound at a tissue site
JP5267910B2 (ja) 2008-02-28 2013-08-21 コスメディ製薬株式会社 マイクロニードルアレイ
ES2691388T3 (es) * 2008-10-07 2018-11-27 Tuo Jin Microagujas poliméricas de transición de fases
US9017712B2 (en) * 2010-07-12 2015-04-28 Shin Poong Pharmaceutical Co., Ltd. Filler composition for tissue reinforcement
CN104379020A (zh) 2012-06-29 2015-02-25 Elc管理有限责任公司 包含一种或多种化妆品成分的微针
JP6546091B2 (ja) 2012-09-13 2019-07-17 アミール，アブラハム 皮膚増大（ｓｋｉｎａｕｇｍｅｎｔａｔｉｏｎ）のための送達デバイスおよび方法
KR101435888B1 (ko) 2012-10-23 2014-09-01 연세대학교 산학협력단 히알루론산을 이용한 생분해성 마이크로니들 제조방법
MX2015008157A (es) * 2012-12-21 2016-02-22 Corium Int Inc Microarreglo para la entrega de agente terapeutico y metodos de uso.
CN104095761A (zh) * 2013-04-08 2014-10-15 上海汇林医药科技有限公司 一种高分子聚合物微针贴剂及其应用
JP6906885B2 (ja) * 2014-11-14 2021-07-21 ロレアル しわを減少させるためのマイクロニードルシート
KR101831948B1 (ko) * 2015-02-13 2018-02-23 주식회사 엔도더마 가교된 히알루론산 하이드로젤을 이용한 마이크로구조체 및 이의 제조방법
CN104921961B (zh) * 2015-05-25 2017-11-17 成都凤磐生物科技有限公司 一种多效修复的可降解生物微针贴
RU2701361C1 (ru) 2015-12-28 2019-09-27 Эндодерма Ко., Лтд. Микроструктура для трансдермального введения и способ её получения

Also Published As

Publication number Publication date
TW201938175A (zh) 2019-10-01
KR101973801B1 (ko) 2019-04-30
TWI718576B (zh) 2021-02-11
TW201808310A (zh) 2018-03-16
US11013670B2 (en) 2021-05-25
MX2018015607A (es) 2019-03-14
US20190336411A1 (en) 2019-11-07
CN109310625A (zh) 2019-02-05
WO2017217818A1 (ko) 2017-12-21
EP3473242A1 (en) 2019-04-24
JP6900405B2 (ja) 2021-07-07
EP3473242A4 (en) 2019-06-19
TWI675666B (zh) 2019-11-01
JP2019523680A (ja) 2019-08-29
KR20170142127A (ko) 2017-12-27

Similar Documents

Publication Publication Date Title
BR112018075703A2 (pt) microestrutura do ácido hialurônico tendo exce-lentes características de solubilidade
EP4279064A3 (en) Drug delivery from hydrogels
BR112016028961A2 (pt) composições compreendendo fibras obtidas por via eletro-hidrodinâmica para administração de dosagens específicas de uma substância ativa à pele ou mucosa
CL2016002753A1 (es) Composición conservante de la madera
BR112014014137A2 (pt) sistema de liberação transdérmica compreendendo buprenorfina
CY1124380T1 (el) Συστηματα διαβλεννογονιας και διαδερμικης χορηγησης
BR112018073703A2 (pt) emplastro para pele ou ferida, composição farmacêutica e método para a liberação de uma substância ativa
BR112015029920A2 (pt) sistema de administração transdérmica
BR112018002414A2 (pt) sistema de distribuição de polímero líquido para administração prolongada de fármacos
BR112015024271A2 (pt) sistema de fornecimento transdérmico
BR112018005905A2 (pt) ?composto, composição farmacêutica, métodos para evitar ou tratar uma doença ou condição, lesões de órgão, hepatotoxicidade e fígado gorduroso, e, uso de um composto?
BR112015015108A2 (pt) cateter com marcações para facilitar o alinhamento
BR112018073460A2 (pt) terapias combinadas usando moduladores do receptor farnesoide x (fxr)
BR112015017246A8 (pt) composição farmacêutica aquosa, seu uso e seringa
BR112016007462A2 (pt) fitonutrientes anti-inflamatórios para uso no tratamento ou prevenção de sinovite
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol
BR112017000849A2 (pt) composição antiaderente
CO2017005201A2 (es) Ácido benzóico, derivados de ácido benzóico y conjugados heteroarilcarboxílico de la oxicodona
BR112015029561A2 (pt) composições agroquímicas aquosas, e, polímero carboxilado solúvel em água
BR112017006918A2 (pt) formulações nanoestruturadas para liberação de silibinina e outros ingredientes ativos para o tratamento de doenças oculares
CL2009002204A1 (es) Composicion intravenosa biocompatible que comprende un factor de coagulacion incluido en microparticulas de acido alginico o sales del mismo.
BR112019005224A2 (pt) forma de dosagem para alívio prolongado
BR112016017496A2 (pt) Composição para acelerar a penetração através da pele, preparação para administração transdérmica e preparação de emplastro de pele
MX2019010289A (es) Composicion en emulsion acida que contiene anestesico local.
BR112018071394A2 (pt) polímero de enxerto, métodos para a preparação de um polímero de enxerto, para a preparação de um sistema de dispensação e para prevenir, tratar ou melhorar um distúrbio médico, composição, preenchedor de tecido macio, uso de um polímero de enxerto, e, kit.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]